gtg agm (a great meeting) !!, page-13

I can see both sides of the coin here as if I had bought in the 20s I would be very frustrated at my "timing" of purchase.

However, if I look at this company it actually has revenue and solid fundamentals which a lot of other bio techs don't have so I am comfortable in my decision and do believe that the market cap will appreciate substantially over the next 12 months with developments and further licensing wins.

I am considering buying more at these levels as I cant see much more downside from here. Just my opinion though.

Tymmsy69